Page last updated: 2024-08-21

thiophene-2-carboxylate and Colitis

thiophene-2-carboxylate has been researched along with Colitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
He, QZ; Liu, HH; Liu, SJ; Liu, TT; Shi, KQ; Wei, P; Zhang, JW; Zhang, JZ	1

Other Studies

1 other study(ies) available for thiophene-2-carboxylate and Colitis

Article	Year
3,6-dichlorobenzo[b]thiophene-2-carboxylic acid alleviates ulcerative colitis by suppressing mammalian target of rapamycin complex 1 activation and regulating intestinal microbiota. World journal of gastroenterology, 2022, Dec-14, Volume: 28, Issue:46 Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Mammals; Mice; Mice, Inbred C57BL; TOR Serine-Threonine Kinases	2022

Article

Year

3,6-dichlorobenzo[b]thiophene-2-carboxylic acid alleviates ulcerative colitis by suppressing mammalian target of rapamycin complex 1 activation and regulating intestinal microbiota.

World journal of gastroenterology, 2022, Dec-14, Volume: 28, Issue:46

Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Mammals; Mice; Mice, Inbred C57BL; TOR Serine-Threonine Kinases

2022